FDA’s Technology Modernization Action Plan
Recent scientific and biomedical advances—from genomic sequencing to development of cell and gene therapies and nanotechnologies— have brought the promise of significant improvements to the health of many millions of Americans. To date, however, we have seen little of this promise in our day-to-day lives because a large and persistent gap separates important scientific advances and the technologies needed to translate those advances into new therapies for patients and new ways to protect the public health.
The FDA’s Technology Modernization Action Plan (TMAP), described in this document, is an important step FDA is taking to address and close this gap. It describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.